Podcasts about Psychiatry

Newly released diary entries and internal emails obtained by Sen. Rand Paul reveal that Dr. Anthony Fauci privately sounded the alarm in 2016 after learning the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) had aerosolized Ebola in a study funded by his own institute. “What idiots,” Dr. Fauci wrote in March 2016. “This should have been a classified experiment, that never should have been done in the first place.” The documents reveal that vaccinated primates exposed to the airborne pathogen suffered severe lung inflammation – with worse outcomes than the unvaccinated. “During the course of those experiments, the DOD noticed that the animals that were vaccinated had more inflammation [in the lungs than] those who were unvaccinated,” Fauci wrote in his diary at the time. “Nonetheless, the idea that the vaccine can do harm is now causing people a great deal of concern.” “Records show NIAID was funding risky research with the Defense Department. And when the results turned problematic, Dr. Fauci argued they should have been classified,” says Sen. Rand Paul. “It is clear additional oversight is needed into what Dr. Fauci's institute was paying for long before COVID.” Peter Navarro Ph.D., the former Senior Counselor to President Trump and author of Why Fauci MUST Rot in Prison, joins Dr. Drew to break down the unsealed diary, disease weaponization, and federal gain-of-function accountability. National security expert Dr. Bradley Thayer examines Chinese Communist Party leverage and geopolitical conflict. Board-certified psychiatrist Dr. Josef Witt-Doerring returns to discuss the latest findings in the Presley Gerber investigation and new studies debunking “addictive personalities.” Peter Navarro Ph.D. served as Senior Counselor to President Trump for Trade and Manufacturing. He holds a Ph.D. in economics from Harvard University and is Professor Emeritus of Economics and Public Policy at UC–Irvine. His latest book is “Why Fauci Must ROT In Prison” available at https://amzn.to/4y0A2j0. Follow at https://x.com/RealPNavarro Bradley Thayer Ph.D. is a founding member of the Committee on the Present Danger China and co-author of “Embracing Communist China: America's Greatest Strategic Failure” and author of “America's 100 Years' War: How to Win Against Communism” available at https://amzn.to/46UrxuI. Formerly, he was a Special Governmental Employee in the Department of Homeland Security. Follow at https://x.com/bradthayer Dr. Josef Witt-Doerring is a board-certified psychiatrist and former FDA Medical Officer, now Medical Director of TaperClinic. He previously worked at Janssen Pharmaceuticals and the FDA's Division of Psychiatry, and hosts the podcast Side Effects with Dr. Josef. Follow at https://x.com/drjosefWD 「 SUPPORT OUR SPONSORS 」 • FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/fatty15⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/paleovalley⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twc.health/drew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 「 ABOUT THE SHOW 」 This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Executive Producers • Kaleb Nation - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://kalebnation.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • Susan Pinsky - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/firstladyoflove⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Content Producer • Emily Barsh - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/emilytvproducer⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, host and podcast chair Sam sits down with Dr. David Puder, outpatient psychiatrist, psychotherapist, and creator of the Psychiatry and Psychotherapy podcast to make the case that therapeutic skills aren't optional for psychiatrists — they're essential.Dr. Puder traces his unlikely path into psychiatry, from nearly pursuing orthopedics to a pivotal stint in Haiti that rewired his priorities, and describes the residency mentor who first showed him the power of a single empathic encounter. From there, the conversation opens up into a wide-ranging exploration of what holistic care really looks like when you stop splitting "biology" from "psychology" and start treating the whole person, including a live exercise in recognizing and working with countertransference, practical advice on personal therapy, and how attachment patterns shape both your patients and your own clinical reactions.Tune in to Dr. Puder's podcast at psychiatrypodcast.com.--Music from #Uppbeat (free for Creators!):https://uppbeat.io/t/torus/layers-of-lifeLicense code: 4BPPLFF6KL9N7G4Q

This week on The Breggin Hour, Peter and I sat down with one of the more wonderful men we know: Sheriff Richard Mack, founder of the Constitutional Sheriffs and Peace Officers Association, the Arizona sheriff who took the federal government all the way to the Supreme Court over the Brady Bill—and won. He has a new book. The title is deliberately offensive. He said so himself, and he meant it that way. The Democrat Murder of America: Demagoguery in the First Degree. The cover is a jackass in a patriotic hat, a knife in its hoof, stabbing the Statue of Liberty in the back. Sheriff Mack admitted it is horrible. That was the point. He wanted your attention. The book site is murderofamerica.com. There is an ebook at $14.92, an audiobook at $17.76, and a paperback at $26.76. They planned those numbers. Columbus. 1776. 2026. This is not a campaign pamphlet for a party. Sheriff Mack said it is not a pro-Trump book and not a pro-Republican book. It is a history book about what is being done to the country from within—and a manual for people who still believe the Constitution and the individual human being are worth defending. You cannot have communism and freedom That was the sentence he kept coming back to. Those philosophies are not cousins. They are not “different paths to the same good.” They are the antithesis of each other. Communism does not recognize civil rights. It does not honor the person. It tells you how many children you may have, what you may say, what you may own, and what you must obey. The promise of forced equality is a lie. The individual is erased. Peter and I have spent years saying the same thing in another language: collectivism—religious, political, or “scientific”—is the opposite of Christianity and of the American founding. The First Amendment begins with faith for a reason. A Creator who made each person in His image is not compatible with a state that claims ownership of the soul and rejects the individuality and unique qualities of each person. Sheriff Mack asked a question the media will not ask the new crop of openly socialist and communist candidates: What will you do with the people who refuse to cooperate? We already know part of the answer. We lived it. COVID was the rehearsal On the show, we talked about the last few years as if they were ancient history. They are not. Children locked inside. Playgrounds closed. Churches shuttered. Babies staring at masked faces for the first years of life. Australians held for months in camps. Planes on which you could remove the mask only to eat—so Sheriff Mack ate peanuts for hours, until they changed the rule to force the little ritual of pull-down, bite, pull-up. Control for control's sake. They learned that a “crisis of the day” can make Americans surrender schools, businesses, worship, and the Constitution. Justice Scalia, in the very case Sheriff Mack won, wrote that the Constitution protects us from our own best intentions. It divides power so we will resist the temptation to concentrate it as an expedient solution to the emergency of the moment. Never let a crisis go to waste. That is not wisdom. That is a method. If you think that chapter is over, Sheriff Mack's warning is simple: wait until the people who admired that machinery hold still more offices. **History they hoped you would forget** The book is full of names younger Americans were never taught. Nikita Khrushchev, General Secretary of the Communist Party of the Soviet Union, told Americans they were gullible. You will not accept communism outright, he said. We will feed you small doses of socialism until you wake up and find you already have communism. We will not need to invade. We will destroy you from within. We will bury you. Sheriff Mack's argument is that a political movement inside the Democrat Party is fulfilling that threat—not because every Democrat is a villain, he said, but because the party's dominant direction is to replace the Constitution with something closer to Marx. He talked about Dorothy Kilgallen, the What's My Line television game show panelist and journalist who interviewed Jack Ruby and then died the same night her JFK notes disappeared—barbiturates and alcohol, ruled an accident, the same pattern as Marilyn Monroe. Vince Foster. The sudden expansion of Vietnam after JFK was gone. The deep state is not a new invention. He talked about CNN's Sarah Sidner, who came to his daughter's house, recorded eighty-five minutes, heard again and again why they were even talking—his Supreme Court victory against the Clinton Justice Department—and then went on Anderson Cooper and mentioned none of it. Peter and I know that pattern. We have been walked out of buildings we were invited into. YouTube banned us for life after we announced *COVID-19 and the Global Predators*. The media is not a referee. It is a participant. Elections, cities, and the Senate Sheriff Mack described a country in which a tourist from Buenos Aires can walk into a New York polling place, register without ID and without English, vote, and fly home to brag. He described the open talk of abolishing or neutering the Senate and packing the Court—so that a handful of giant cities decide the fate of small states. Destroy the Constitution, he said, and you destroy the country. He also said something we hear too rarely: there are good Democrats, including Christians, who have been lied to. The book is written to be handed to them. Start with the epilogue, he suggested. Then talk. That is not hatred. That is an invitation to wake up from indoctrination. The smartest person in the room, he said, is the one who can recognize his own brainwashing. A peaceful manual, while peace is still possible Peter's closing on the hour was short: buy the book. You are not only buying pages. You are supporting one of the great living voices for constitutional liberty in this country. Sheriff Mack and co-author Dan Perkins talked, while they were writing, about what happens if the book actually gains traction. They have already been smeared. They know the next step. Perkins told him he hoped their wives would be taken care of. That is not melodrama. That is what it costs now to say plain things in public. The alternative they offer is still peaceful: know the history, refuse the next crisis-of-the-day, restore local accountability, protect the sheriff's oath to the Constitution rather than to Washington, and come together as good people who still love this country. We are of a generation that did duck-and-cover, that watched people shot trying to leave East Germany, that saw COVID used as a nationwide obedience drill. Younger people have been propagandized in school and have not seen the same failures with their own eyes. That is why a book like this matters. It is a history lesson and a warning in one. Christmas will be here before we think about it. Give this book as a gift of freedom—one for you, one for the family member who still believes the slogans. The website again: **murderofamerica.com** *The Breggin Hour* airs on America Out Loud. We will keep talking. We refuse to stop. The truth still sets people free. But first they have to hear it. — Ginger, with Peter       ________   Learn more about Dr. Peter Breggin's work: https://breggin.com/   See more from Dr. Breggin's long history of being a reformer in psychiatry: https://breggin.com/Psychiatry-as-an-Instrument-of-Social-and-Political-Control   Psychiatric Drug Withdrawal, the how-to manual @ https://breggin.com/a-guide-for-prescribers-therapists-patients-and-their-families/   Get a copy of Dr. Breggin's latest book: WHO ARE THE “THEY” - THESE GLOBAL PREDATORS? WHAT ARE THEIR MOTIVES AND THEIR PLANS FOR US? HOW CAN WE DEFEND AGAINST THEM? Covid-19 and the Global Predators: We are the Prey Get a copy: https://www.wearetheprey.com/   “No other book so comprehensively covers the details of COVID-19 criminal conduct as well as its origins in a network of global predators seeking wealth and power at the expense of human freedom and prosperity, under cover of false public health policies.”

Prof. Gordon Parker was almost too smart for me to interview. Nonetheless, I gave it a crack and we covered some hefty subject matter and explored a few things on the lighter side, like Crapsules. And yes, they are actually what they sound like. Enjoy your breakfast. The good Prof. is one of Australia’s most distinguished and respected psychiatrists and mental health researchers who has published more than 1,000 scientific papers, written 23 books, is the founder of the Black Dog Institute and is an Order of Australia medal recipient (OAM). He’s also a ripper Bloke and I enjoyed our conversation.See omnystudio.com/listener for privacy information.

Madonna called Sabrina Carpenter out for taking a week to reply to her text. But why does it take some people so long to reply to texts? Jonathan asked Brendan Kelly, Professor of Psychiatry at Trinity College Dublin.

Madonna called Sabrina Carpenter out for taking a week to reply to her text. But why does it take some people so long to reply to texts? Jonathan asked Brendan Kelly, Professor of Psychiatry at Trinity College Dublin.

Following the death of 27-year-old Presley Gerber inside a Santa Monica sober living facility, board-certified psychiatrist and former FDA Medical Officer Dr. Josef Witt-Doerring of TaperClinic joins Dr. Drew to examine the fatal risks of overmedicating with psychiatric drugs. Dr. Witt-Doerring analyzes Gerber's disclosures of fluctuating benzodiazepine doses without daily medical oversight, the physiological hazards of unmonitored psychiatric medication tapers, and the emerging panic over gas station kratom. Dr. Mary Talley Bowden breaks down the brewing revolt within the MAHA movement, as health freedom leaders issue an ultimatum to Pres. Donald Trump and RFK Jr. demanding the removal of the mRNA vaccine platform. California Department of Public Health whistleblower Ronald Owens Jr., author of “Muzzled Truth,” exposes how state officials suppressed early COVID-19 treatment warnings from 40 million residents and examines former HHS Secretary Xavier Becerra's controversial public remarks on vaccine mortality. Dr. Mary Talley Bowden completed her residency at Stanford University and is board-certified in both Otolaryngology and Sleep Medicine. She is the author of “Dangerous Misinformation: The Virus, the Treatments, and the Lies” available at https://amzn.to/4rF16CW. Follow at https://breathemd.org Ronald F. Owens, Jr. worked at the California Department of Public Health (CDPH) as an Information Officer 2 during COVID, where he says he learned that then-HHS Secretary Xavier Becerra said COVID-19 vaccines were “killing people.” He is the author of “Muzzled Truth: How The California Dept. of Public Health Rejected COVID-19 Treatment and Vaccine Health Risks Warnings.” Find more at https://muzzledtruth.com Dr. Josef Witt-Doerring is a board-certified psychiatrist and former FDA Medical Officer who is Medical Director of TaperClinic, one of the only practices focused exclusively on helping patients safely de-prescribe from psychiatric medications. He previously worked at Janssen Pharmaceuticals and the FDA's Division of Psychiatry, and hosts the podcast Side Effects with Dr. Josef. Follow at https://taperclinic.com 「 SUPPORT OUR SPONSORS 」 • FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/fatty15⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://drdrew.com/paleovalley⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twc.health/drew⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 「 ABOUT THE SHOW 」 This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Executive Producers • Kaleb Nation - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://kalebnation.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ • Susan Pinsky - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/firstladyoflove⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Content Producer • Emily Barsh - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://x.com/emilytvproducer⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, we explore one of the most haunting lines from Kurt Cobain's suicide note: “Why don't you just enjoy it?” and the devastating response: “I don't know.” We unpack why human beings struggle to feel joy through the lenses of neuroscience, psychology, evolution, trauma, addiction, overstimulation, and modern culture. From dopamine and cortisol to loneliness, achievement addiction, and the pressure to perform happiness, this episode examines why so many people feel disconnected from their own lives — and what history, philosophy, pop culture, and human connection reveal about truly feeling alive.Topics include:Why the brain adapts to pleasure and noveltyThe difference between stimulation and fulfillmentTrauma, stress, and the nervous system's impact on joyEvolutionary reasons humans struggle with contentmentWhy modern life can make us spectators instead of participantsThe role of relationships, meaning, awe, and shared strugglePop culture references from Nirvana to Black Mirror to Ted LassoHow to reconnect with ordinary moments and meaningful experiencesWhat we might say to someone who can't “just enjoy it”Thrive With Leo Coaching: If you want to reduce your psychological pain, regain your purpose and forge your own path, go to www.thrivewithleo.com to begin your journey.If you or anyone you know is considering suicide or self-harm, or is anxious, depressed, upset, or needs to talk, there are people who want to help:In the US: Crisis Text Line: Text CRISIS to 741741 for free, confidential crisis counseling. The National Suicide Prevention Lifeline: 1-800-273-8255 or 988The Trevor Project: 1-866-488-7386Outside the US:International Association for Suicide Prevention lists a number of suicide hotlines by country. Click here to find them.Gambling Addiction: 1-800-GAMBLER

Dr. Tesha Monteith talks with Dr. Tamara Pringsheim about the updated American Academy of Neurology (AAN) and American Headache Society (AHS) guidelines on pharmacologic treatment for migraine prevention in adults.  Read the related article in Neurology®. Disclosures can be found at Neurology.org.  Show transcript:  Dr. Jose Merino (00:08): This is Jose Merino, editor-in-chief of the Neurology Family of Journals. The Neurology Podcast provides practical information to neurologists and other clinicians to help them provide better care for their patients. Thanks for listening and have a great week. Dr. Tesha Monteith (00:23): Hi, this is Tesha Monteith with the Neurology Podcast. I'm excited to talk to you today about the update in Migraine Guideline: Pharmacologic Treatment for Migraine Prevention in Adults: Practice Guideline Recommendations, a report of the American Academy Neurology Guidelines Subcommittee, and the American Headache Society. Since the last guideline in 2012, there's been a lot of new advances, including the introduction of CGRP inhibitors for acute and preventive treatment. (00:53): With me to discuss is the lead author, Tamara Pringsheim, a neurologist at the Department of Clinical Neurosciences, Psychiatry, Pediatrics, and Community Health Sciences at the University of Calgary. How are you, Tamara? Dr. Tamara Pringsheim (01:06): Great. Thank you for asking me to talk to you about this. Dr. Tesha Monteith (01:09): Why don't you tell me a little bit about yourself and how you got involved in this work? Dr. Tamara Pringsheim (01:14): Sure. I've been working as a methodologist for the American Academy of Neurology Guidelines Subcommittee for a number of years, since 2015. Prior to that, I was a member of the guideline development subcommittee from 2011. I've worked on a number of different guidelines across neurological conditions. Dr. Tesha Monteith (01:36): Great. So how do these new guidelines compare, just broadly speaking, with the older guidelines? Dr. Tamara Pringsheim (01:43): I guess since the last guidelines were published more than 10 years ago, we've had changes to our methodological process. We had a major update to our guideline process manual in 2017, and guideline methodology has continued to evolve over that time period. And as well, a number of targeted treatments for migraine have come out. So there's been an explosion of evidence, particularly in the last five to seven years. And so we have a whole new class of medications available for migraine prevention, which really target our underlying understanding of the condition, whereas most of the other medications were discovered through serendipity. Dr. Tesha Monteith (02:33): So I know that you reviewed over 200 randomized controlled trials. And so how was the quality or confidence of the evidence determined? Dr. Tamara Pringsheim (02:47): With our process, we start by rating risk of bias for every article. This basically gets at a number of different features related to the clinical trial methodology and reporting, and it helps us determine how confident we are in the evidence. In order for us to be highly confident that the results that we are seeing reflect the truth, we typically need to have at least two Class 1 studies for any intervention outcome pair. The effect size estimate also has to meet a certain threshold in terms of the effect size and the precision surrounding that estimate. So if we feel that based on what the panel decides in terms of what is the minimal clinically important difference between an intervention and placebo, that will help us determine our confidence in the evidence. (03:51): So there's this critical coming together of the number of studies, the quality of studies, the effect size, and the precision of the evidence that helps us determine our confidence in the evidence. And all of this is done behind the scenes using a very algorithmic approach so that these rules are faithfully applied across the different interventions we're looking at. This complexity makes it hard for people to understand why certain drugs land in a certain area, but it's one of the things that we do to make this process standardized and rigorous. Dr. Tesha Monteith (04:37): So I do want to talk to you about that, where drugs have landed. One newer thing was that the review was not just episodic migraine, but also chronic migraine. Dr. Tamara Pringsheim (04:47): Yes. Dr. Tesha Monteith (04:48): Were there important differences in the strength of evidence between these populations? Dr. Tamara Pringsheim (04:53): One thing that's really important to remember is that the use of the term chronic migraine is fairly new. So a lot of the trials of the older headache preventive medications were done in the 80s and the 90s. And at this time, there wasn't a definition which distinguished chronic migraine in particular. So a lot of the trials for amitriptyline, for example, were not done in a purely episodic or chronic migraine population. And so this really contrasts with the newer studies where these populations were well-defined. And so we're going to have higher quality evidence or evidence specifically for chronic migraine with the new drugs, whereas for the old drugs, we won't have that. Dr. Tesha Monteith (05:50): Let's get into the preventive treatments that had the strongest level of evidence for episodic migraine. Dr. Tamara Pringsheim (05:57): We had high confidence in the evidence for two of the CGRP medications, erenumab and galcanezumab. Again, these high confidence in the evidence statements are based on the fact that for both these drugs, there were multiple Class 1 studies showing that they were efficacious. And the effect size was in the range that was pre-specified. So the lower level of the 95% confidence interval was clearly higher than what we decided was the minimal clinically important difference. Both these drugs, one had two Class 1 studies, one had three Class 1 studies, so we could be very highly confident that these two medications were efficacious. (06:50): Now for the moderate confidence drugs, we have a longer list for episodic migraines. So it includes atogepant, eptinezumab, fremanezumab, propranolol, rimegepant, topiramate, and valproate, and then a slightly longer list for the low confidence drugs. So amitriptyline, bisoprolol, flunarizine, fluoxetine, levetiracetam, metoprolol, nifedipine, pizotifen, and telmisartan. (07:18): And for this outcome, I'm specifically talking about episodic migraine headache days. Now, one of the layers of complexity, again for this guideline, is that we had a few different outcomes that we were looking at. So the two main outcomes we were looking at were the headache frequency, the change in the number of headache days, but also the 50% responder rate. That's the proportion of people in the treatment group who had at least a 50% reduction in their headache frequency. And some drugs would make it for one endpoint, but not the other. And this is an important nuance that, again, adds complexity to our data synthesis. Dr. Tesha Monteith (08:06): And what about for chronic migraine? Dr. Tamara Pringsheim (08:08): So for chronic migraine, for the number of headache days, we had high confidence for fremanezumab, galcanezumab and onabotulinumtoxinA, and moderate confidence for atogepant, eptinezumab, erenumab, topiramate, rimegepant, and valproate. We didn't have any medications that were in the low confidence in the evidence category. Dr. Tesha Monteith (08:33): Oftentimes in the newer clinical trials, we're looking at change in monthly migraine days, but interesting that you looked at headache days. Dr. Tamara Pringsheim (08:42): Yeah. So another difficulty is that there's not always consistency in what's reported. So some trials would report headache days and some trials would report migraine days per month. Wherever possible, we use the change in the number of days with migraine. And where this was not present, we would use headache days. Dr. Tesha Monteith (09:08): Now, a drug that we use very often in clinical practice is rimegepant, which has a dual benefit of acute attack treatment as well as prevention. And that was rated as low confidence, but in a recent International Headache Society, Italian guidelines, that was noted as moderate quality evidence, strongly in favor of. What do you think that discrepancy was about? Is that a matter of outcomes or? Dr. Tamara Pringsheim (09:38): This guideline includes clinical trials that were published up until June of 2024. And so at that time, the only trial of rimegepant versus placebo that was published was in a population of patients that had episodic or chronic migraine. The population was combined. And so we only have one study. And as I was explaining at the beginning, in order for us to have high confidence in the evidence, we have to have at least two Class 1 studies and the minimal clinically important difference has to meet a certain threshold. So for rimegepant in June of 2024, there's only one study published versus placebo. So the highest possible confidence in the evidence we could have for rimegepant based on the fact that just one study would be moderate. (10:38): The reason why it's not listed in recommendation 3A as high or moderate confidence is because while we had moderate confidence in the evidence for rimegepant on the number of headache days, we had low confidence in the evidence for the 50% responder rate. And that's because for the 50% responder rate, it did not meet the pre-specified cutoff with respect to the minimally clinically important difference. (11:11): So again, it's a small nuance in the evidence, but for an evidence-based guideline, we really pay attention to these things. I know it makes it complex and hard for people who are not immersed in the evidence to understand. This is part of the rigor. There's a temptation to oversimplify things so that it's easy to understand, but that's really one of the strengths of the AAN process is that we take the evidence very seriously. We are truly evidence-based. We are going through every data point very carefully, and so that you should feel confident when you see that we've rated these medications as a higher moderate confidence, that we've really looked and evaluated these data points very carefully. Dr. Tesha Monteith (12:01): We can say that different guidelines have different outcomes. And to your point, it's more than just the data. It's your pre-specified process that then led to those recommendations, right? Dr. Tamara Pringsheim (12:14): Yeah. And I feel pretty confident that if we were to update the evidence, including the last two years, that rimegepant would move up, right? Because just looking even quickly now, we can see that since 2024, there have been several additional studies published. So now we wouldn't just be basing our evidence review on one placebo controlled study. There have been several more, the medications FDA approved. Dr. Tesha Monteith (12:44): Right. Dr. Tamara Pringsheim (12:45): I don't think anyone should change their practice based on this and people should be using rimegepant. That's not the message that we're trying to send. Dr. Tesha Monteith (12:54): That's really important. Dr. Tamara Pringsheim (12:55): Yes. We are not on a campaign to say that rimegepant is not a treatment option. As you can see, it is listed and it is in the guidelines. It's just based on the data we had available, we had low confidence in one of the outcomes, the 50% responder rate. So I hope that makes sense. Dr. Tesha Monteith (13:14): Yeah, I think it makes sense. It's the processes, it's a 2017 guideline manual, and that does make sense. So thank you for that clarification because a lot of our clinicians will be asking questions about this. Dr. Tamara Pringsheim (13:26): I mean, the same goes for another drug, candesartan is the other one. Dr. Tesha Monteith (13:30): Yeah. Candesartan recently had a paper published in the Lancet. Dr. Tamara Pringsheim (13:33): Yes. Dr. Tesha Monteith (13:33): And it did well, and people are using candesartan. Dr. Tamara Pringsheim (13:38): Yes. Yes, exactly. I prescribe candesartan for migraine prevention. At the time we did the evidence review, we had a couple of positive studies, a couple of negative studies. And when we put the data together, it came out as very low confidence because there's a discrepancy. And then we have a huge trial published that is a positive study, but it came out in 2026. It was not part of our evidence review. We don't say anywhere in the guideline, don't use candesartan, right? We don't say that. We highlight the drugs for which we have the confidence in the evidence and put them in there. But we need to remember that new drugs are coming out all the time and that they didn't factor into our decision making. (14:26): So again, I hope that people don't read the guideline and say, "Oh my God, I can't use candesartan." That's not true. Dr. Tesha Monteith (14:33): So one thing I want to look at is quality of life outcomes. That was something also not seen in the first or the 2012 guidelines. And so how did you look at quality of life outcomes and how should we consider them? Dr. Tamara Pringsheim (14:47): Yeah, so we wanted to make sure that we incorporated patient reported quality of life outcomes in the guideline, recognizing that this is very important. And the newer trials of the more recent medications have been incorporating patient reported quality of life outcomes in their clinical trials. This adds overall credibility that we are incorporating into our decision-making evidence that not only are patients' number of headache days decreasing, but their quality of life is improving because that's important to patients and hence is important to us. (15:31): So we used outcomes from validated measures of migraine related quality of life. So there's the MIDAS, there's the HIT-6, and there's something called the migraine specific questionnaire, which has three subscales. One is emotional function, one is role function preventive, and one is role function restriction. And then a few studies use something called the migraine physical function impact diary. So those were the main instruments that we looked at. And again, we had a pre-specified minimally clinically important difference on these instruments that we looked at. (16:19): And we had a reasonable amount of data, not as much data as we had for headache days or the responder rate, but certainly again, for the CGRP antagonists, we had high confidence in the evidence for galcanezumab, for example, in episodic migraine. And for chronic migraine, we had moderate confidence in the evidence for a number of medications including topiramate and onabotulinumtoxinA. So these quality of life measurements seem to be increasingly used in our modern clinical trial era. Dr. Tesha Monteith (17:07): Great. Another question is just thinking about some of the limitations of this work. There were very few high quality head-to-head trials. How does that limit your comparative effectiveness data? Dr. Tamara Pringsheim (17:19): This is a major issue that most, but not all of the head-to-head trials were investigator-led. Many were done a very long time ago before the modern clinical trial era, and so the quality of these studies was low. And also they were not non-inferiority studies. So basically the only question they could answer is whether drug A is better than drug B based on their trial protocol and methodology. And for most of the comparisons, we have very low quality evidence, so we really cannot support or refute that drug A is better or worse than drug B. So we can't really say anything. There were a few instances where we could say that drug A is better than drug B, but it's low confidence evidence, very few comparisons. (18:17): Some evidence is emerging so that some of the CGRP drugs are being compared to some of the older drugs now with the hope that we can prescribe these sooner to migraine patients. That evidence will probably emerge in the coming years. Dr. Tesha Monteith (18:31): And another question is how should these guidelines be incorporated in clinical practice also while balancing tolerability, comorbidities, patient preference, reproductive considerations, access, and costs? Dr. Tamara Pringsheim (18:47): So we have the evidence synthesis. So you can say, okay, this is the evidence. These are the effect sizes. This is the number of studies to support this outcome, that outcomes. You have the details in the systematic review, right? And then how do you take those details and apply them in the practice? And that's the art of medicine. And we don't make decisions without our patients. All of our decisions are collaborative. I say to my patients, "It's my job to tell you what your options are. It's your job to discuss these options with me and for us to make a decision together regarding which one is the best for you in your situation." (19:30): And that's what we're trying to do in the recommendations. In the recommendation statements, you'll see that in this specific situation, this might be a better choice. We talk a lot about when you're going to decide to even start a preventive and the importance of shared decision making, that those are our first two sets of recommendations. Recommendations one and two are about those things. (19:56): And then our recommendation three statements just tries to gently offer some advice on when you should think about which medication, where efficacy is the priority, tolerability is the priority, long-term harms, cost. Cost is a really tricky one because cost really depends on the person's specific pharmaceutical formulary plan and healthcare insurance. I know that for some patients, their insurance plans require a certain number of oral medications to be tried before an injectable like a botulinum toxin or a subcutaneous medication or one of the newer medications can be prescribed. Dr. Tesha Monteith (20:41): So you put a lot of work in this, your team, the American Academy of Neurology, the American Headache Society, outstanding work. What should we take away from this? Dr. Tamara Pringsheim (20:52): I think that we should take away that a lot of work is being done by headache neurologists and neuroscientists who are interested in headache to develop new treatments for people with migraine. I think that the CGRP drugs are a major advance and that now we have many new medications that are specifically designed for migraine treatment and these treatments are changing people's lives for the better. I think it's brought new hope to people with migraine and it's an exciting time to be a clinician who treats patients with migraine when you have several new medications where the companies have invested the time to do the research, do well-designed clinical studies, and that we can feel confident that these medications are helping our patients. Dr. Tesha Monteith (21:51): Excellent. I couldn't have said that better. Thank you again for your work and your time and for being on our podcast. Dr. Stacey Clardy (22:00): This is Stacey Clardy, your podcast editor. If you've enjoyed the podcast, please take a few moments to subscribe, rate, and review the Neurology Podcast through Apple Podcasts, Google Podcasts, Spotify, or wherever you listen. And remember, you can always head to neurology.org/podcast for our full list of past episodes, or you can also search by keyword on the podcast app for any neurology specific topics.  

In this episode, John Walkup, MD, President of the American Academy of Child and Adolescent Psychiatry and Chair of the Pritzker Department of Psychiatry and Behavioral Health at Ann and Robert H. Lurie Children's Hospital of Chicago, joins the podcast to discuss expanding access to child psychiatric care within the current workforce and the growing role of collaborative care. He also shares insights on the benefits and concerns surrounding shorter training pathways and how new approaches to care delivery could help address the need for pediatric behavioral health services.

What if the way we think about mental health is actually making things worse?In this episode, I sit down with Dr. Sami Timimi, retired child and adolescent psychiatrist, psychotherapist, author, and longtime critic of the medicalization of human distress.And this conversation goes straight to the foundations.We talk about a question I've been asking for years: What happens when we take ordinary—and sometimes extraordinarily painful—human experiences and turn them into psychiatric diseases?Dr. Timimi argues that psychiatric diagnoses are not diagnoses in the medical sense at all. Unlike diabetes, cancer, or other medical conditions, psychiatric diagnoses have no objective biological marker that establishes the condition. Instead, they describe collections of behaviors and experiences—and then, far too often, we use the description as though it explains the person.That distinction matters.Because once we believe our diagnosis explains us, we may stop asking deeper questions: What happened to me? What am I responding to? What does my pain mean? What have I survived? What have I learned to believe? And how might my current struggles make sense in the context of my actual life?We also turn the same critical lens toward psychotherapy. Dr. Timimi challenges the increasingly technical model of therapy in which a diagnosis supposedly determines the treatment. Instead, we talk about therapy as fundamentally relational: one human being encountering another, without reducing that person to a pathology or assuming the therapist already knows what needs to be “fixed.”We discuss resilience, agency, suffering, meaning-making, the therapeutic relationship, and why understanding your pain as a reasonable human response may actually offer something the diagnostic model often cannot: Hope.One of my favorite ideas from this conversation is beautifully simple: stories of suffering are also stories of survival. There is always more to you than your pain. And there is always more to a human being than a diagnosis.

What actually makes psychotherapy work—and how does meaningful, lasting psychological change happen? In this episode of Inner Voice: A Heartfelt Chat with Dr. Foojan, Dr. Foojan Zeine speaks with Dr. Jeffrey Smith, psychiatrist, psychotherapist, author, educator, and Clinical Professor of Psychiatry at New York Medical College. Dr. Smith explains the science of psychotherapy, psychotherapy integration, psychological change, emotional healing, and the mechanisms that help people change deeply rooted patterns. Drawing from decades of clinical experience, he brings together insights from different psychotherapy approaches and explains how therapists can understand and facilitate meaningful change. The conversation explores inner parts, survival strategies, schemas, emotional memory, behavioral change, mindfulness, self-observation, acceptance, values, therapeutic relationships, and accurate empathy. A central theme is that lasting change is not simply about understanding the past. Psychotherapy can help activate old patterns while introducing new perspectives and experiences—creating opportunities to develop healthier ways of thinking, feeling, relating, and responding. In This Episode: • How psychotherapy actually works • What creates lasting psychological change • Psychotherapy integration and effective therapy • Inner parts and protective survival strategies • Schemas and emotional patterns • Emotional activation and new experiences • Disconfirming information and changing old beliefs • Behavioral change and self-observation • Mindfulness, acceptance, and psychological awareness • The role of values in psychotherapy • Therapeutic safety and accurate empathy • Why the therapeutic relationship matters Chapters: 00:00 Introduction: How Psychotherapy Works 01:39 Understanding the Inner Self 02:11 When Survival Strategies Become Outdated 05:10 How Does Psychotherapy Actually Work? 07:39 Meet Dr. Jeffrey Smith 11:21 The Foundation of Psychotherapy 12:25 Mechanisms of Psychological Change 13:14 Compassion and the Inner Self 16:35 Understanding Different Parts of the Self 18:58 Protective Parts and Survival Strategies 20:10 Acceptance and Healing 24:08 Schemas and Emotional Memory 25:13 Why Emotional Activation Matters 26:40 Disconfirming Information and Change 29:18 How Behavior Creates Change 31:13 Self-Observation and Awareness 34:54 Mindfulness and a New Perspective 36:02 A Practical Inner Parts Exercise 36:59 The Role of Values in Psychotherapy 40:05 Safety and the Therapeutic Relationship 41:05 Why Psychotherapy Is Interpersonal 42:01 Accurate Empathy in Therapy 44:17 Dr. Smith's Book: How Psychotherapy Works 45:31 Where to Find Dr. Jeffrey Smith 46:08 Closing Thoughts About Dr. Jeffrey Smith: Dr. Jeffrey Smith is a psychiatrist, psychotherapist, author, educator, and Clinical Professor of Psychiatry at New York Medical College. He is a former President of the Society for the Exploration of Psychotherapy Integration (SEPI) and has devoted his career to understanding how psychotherapy creates meaningful change. Learn more about Dr. Jeffrey Smith and his work at HowTherapyWorks.com. About Inner Voice: Inner Voice: A Heartfelt Chat with Dr. Foojan explores psychology, psychotherapy, emotional wellbeing, relationships, self-awareness, personal growth, and the science of meaningful change. Explore the International Awareness Integration Institute and learn more about psychotherapy, coaching, Awareness Integration Theory (AIT), and integrative wellbeing at IAII.life.

The Minister for Housing James Browne has directed officials to examine online bidding portals.The worry is that these bidding portals mimic gambling products, and in doing so, drive up house prices.So, are these bidding sites leading to the gamification of the housing market?Colin O'Gara is Professor of Psychiatry at UCD, and he joins Ciara to discuss.

In this episode of Oncology On the Go, Daniel C. McFarland, DO, spoke with Yesne Alici, MD, who oversees Memorial Sloan Kettering Cancer Center (MSKCC)'s medical aid in dying (MAID) program. Together, they explored what MAID means for oncology practice now that it is legal in New York State.Alici defined MAID as the legal practice in which a terminally ill, capacitated adult with a life expectancy of less than 6 months may request a prescription that they self-administer to hasten death. Self-administration, she noted, is the main distinction between MAID and euthanasia, which is not legal anywhere in the US. MAID is currently legal in 14 states and Washington, DC, giving roughly 1 in 3 US adults access, according to Alici. Even so, it accounts for less than 1% of all deaths in states where it is legal, and not every patient who inquires goes on to pursue it.Drawing on MSKCC's experience fielding inquiries from patients in New Jersey since 2019, Alici described a population that was mostly older and predominantly female, with about one-third of patients having early-stage cancer when they asked and most still receiving treatment. Nationally, the top reasons patients inquire are loss of dignity, loss of control, and loss of ability to enjoy activities, rather than physical symptoms like pain or shortness of breath.The conversation also walked through New York's safeguards, including multiple requests, 2 neutral adult witnesses, a decision-making capacity assessment, and a mandatory psychiatrist or psychologist evaluation, a requirement shared only with Hawaii. Alici argued that these assessments should be psycho-oncology informed and stressed the importance of approaching each request with neutrality, cautioning that conflating MAID with suicidal ideation risks alienating patients.McFarland shared a challenging case involving voluntarily stopping eating and drinking, reflecting on clinicians' own moral discomfort and on broader philosophical concerns about the romanticization of death. The pair also discussed the need for more research, the role of palliative care, and conscientious objection. Alici closed by urging oncologists who object to MAID to ensure that patients still have a path to discuss their inquiry, noting that New York law mandates offering a palliative care referral.McFarland is the director of the Psycho-Oncology Program at Wilmot Cancer Center and a medical oncologist who specializes in head, neck, and lung cancer, in addition to being the psycho-oncology editorial advisory board member for the journal ONCOLOGY®. Alici is vice chair of clinical operations in the Department of Psychiatry and Behavioral Services, clinical director, associate attending psychiatrist, and medical director of the Biobehavioral Health Clinic at MSKCC.

In this episode, John Walkup, MD, President of the American Academy of Child and Adolescent Psychiatry and Chair of the Pritzker Department of Psychiatry and Behavioral Health at Ann and Robert H. Lurie Children's Hospital of Chicago, joins the podcast to discuss expanding access to child psychiatric care within the current workforce and the growing role of collaborative care. He also shares insights on the benefits and concerns surrounding shorter training pathways and how new approaches to care delivery could help address the need for pediatric behavioral health services.

Episode 167Chefs on the Spectrum: An Innovative Employment Program for Autistic and Neurodivergent People, with Chef Franklin Becker and Chef Joseph ValentinoThis episode features Chef Franklin Becker and Chef Joseph Valentino discussing their work with the Chefs on the Spectrum program at Chef Franklin's restaurant Point Seven in New York City. Chef Franklin explains how his personal experience as a father of an autistic son inspired him to create the program, which connects autistic adults with meaningful careers in professional kitchens while helping restaurants become more inclusive workplaces. Chef Joe shared his journey from facing job rejections and difficult work environments to thriving as a chef at Point Seven, where he has developed important skills like managing ticket orders and preparing mise en place properly. The discussion highlighted how Joe's presence has positively impacted the entire kitchen team by teaching tolerance, acceptance, and compassion, while also breaking down stigma about autism in the culinary industry.Learn more on our website See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The Youth Suicide Prevention Initiative (YSPI) is a multidisciplinary effort by the Department of Psychiatry at C.S. Mott Children's Hospital dedicated to expanding and strengthening suicide prevention and mental health care. The team is committed to building an empathetic, skilled and engaged workforce to respond to the youth mental health crisis. Learn more about YSPI as several team members stopped by The Wrap for an in-depth conversation. Check it out today! Hosted on Acast. See acast.com/privacy for more information.

Psychedelic therapy is increasingly becoming a part of clinical decision making, as evidenced by Compass Pathways' announcement earlier this year of successful trial results for COMP360 psilocybin for treatment-resistant depression. Kimberly Chew, Senior Counsel, Husch Blackwell LLP, and L. Alison McInnes, MD, MS, Director of Psychedelic Medicine, Mindful Health Solutions, discuss the clinical realities and legal gray zones of psychedelic therapies as they move from controlled trials into real-world practice. They cover recent developments, the gap between clinical trials and clinical practice, Risk Evaluation and Mitigation Strategies, and what good early adoption looks like in the clinical setting. Kimberly and Alison authored a Health Law Weekly article on this topic.Watch this episode: https://www.youtube.com/watch?v=EE_HTFUWbG8Read Kimberly and Alison's Health Law Weekly article: https://www.americanhealthlaw.org/content-library/health-law-weekly/2026/april/10/psychedelics-in-psychiatry-early-medical-adoption Essential Legal Updates, Now in AudioAHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Comprehensive members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.Stay At the Forefront of Health Legal EducationLearn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/. 

In this episode of Better Edge, Shan H. Siddiqi, MD, discusses how connectivity-based, image-guided neuro-navigation is refining transcranial magnetic stimulation (TMS) protocols for treatment-resistant depression, anxiety and other psychiatric disorders. He details findings from a recent JAMA Psychiatry trial that found that this approach raised response rates from 60% to 80%, with lesion-network mapping potentially expanding TMS use to bipolar disorder, PTSD, OCD and Parkinson's disease. Dr. Siddiqi also highlights Northwestern Medicine's emerging interventional psychiatry program, which integrates TMS, ketamine and ECT services with a broad portfolio of neuromodulation clinical trials and a newly accredited brain stimulation fellowship.

In this episode, Dr Tsen Vei Lim talks to Dr Martine Skumlien and Professor Valentina Lorenzetti. Martine is a research fellow at King's College London in the UK and Valentina is a professor at the Australian Catholic University in Australia. The interview covers Martine and Valentina's research article on brain reward function in young people with cannabis use disorder.The idea that the brain reward system is affected in people with cannabis use disorder [01:28]How our understanding of the neuroscience behind cannabis use disorder affects how we treat cannabis use disorder [03:46]The novel contribution of Martine and Valentina's study [06:06]How Martine and Valentina investigated the brain reward system in cannabis use disorder [08:18]The key findings from the study [09:24]How we think about the neuroscience of cannabis use disorder [12:33]How do we make sense of the findings alongside the current evidence base [14:33]How the findings sit in the theory of addiction as a brain disease [19:50]The wider implications on future treatment of cannabis use disorder [21:55]About Tsen Vei Lim: Tsen Vei is an academic fellow supported by the Society for the Study of Addiction, currently based at the Department of Psychiatry at the University of Cambridge. His research integrates computational modelling, experimental psychology, and neuroimaging to understand the neuropsychological basis of addictive behaviours. He holds a PhD in Psychiatry from the University of Cambridge (UK) and a BSc in Psychology from the University of Bath (UK). About Martine Skumlien: Martine is a Research Fellow at the King's College London Social, Genetic & Developmental Psychiatry Centre. Her work focuses on cannabis harm reduction, policy, and impact on the brain. She was previously a research associate in the National Institutes for Health and Care Research (NIHR) Policy Research Unit in Addictions where she conducted research to inform policy within the drug and addictions field, and at the University of Bath where she carried out mixed-methods research into drug checking and detection of novel psychoactive substances. She earned her PhD from the University of Cambridge, investigating how cannabis use influences motivation and reward processing in the brain.About Valentina Lorenzetti: Valentina is a professor, founding Lead of the Neuroscience of Addiction & Mental Health Program, and co-founding Deputy Director of the Healthy Brain and Mind Research Centre at the Australian Catholic University in Melbourne Australia. She also serves as Senior Editor of the journal Addiction. Valentina has dedicated her career to understanding the neurobiology behind how people move into, and out of, addiction and entrenched mental health problems, across Australia, the UK, and Brazil, with a consistent focus on identifying with precision the core neurocircuitry affected and translating that understanding into effective intervention. Valentina's program combines advanced multimodal neuroimaging, neuromodulation tools, global multi-site cohorts, and novel interventions such as cannabidiol, craving management strategies, and neurofeedback. Tsen Vei, Martine and Valentina have no conflicts of interest to declare.Original article: Brain reward function in young people with cannabis use disorder: A functional magnetic resonance imaging study https://doi.org/10.1111/add.70492 The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.Music provided by Jack Shakespeare. Hosted on Acast. See acast.com/privacy for more information.

When a catastrophic outcome puts psychiatric treatment under a public microscope, the legal and media fallout often flattens complex care into oversimplified narratives of provider negligence. In this episode, host Sharlee Dixon and Peter Fenger unpack the clinical and systemic implications of the Lindsay Clancy trial, moving past courtroom drama to address the quiet anxiety currently reshaping mental health practice. They examine how fragmented communication across prescribers and reliance on templated documentation left care vulnerable to legal scrutiny, while detailing the cognitive illusion of hindsight bias that leads evaluators, and clinicians themselves, to treat tragic outcomes as retroactively obvious. Sharlee and Peter break down what the legal standard of "reasonable care" actually demands in clinical records versus the trap of defensive novella-writing, address the "second victim phenomenon" affecting half of healthcare workers after adverse events, and discuss how sensationalized coverage risks causing vulnerable postpartum mothers to mask symptoms out of fear.   Follow Behavioral Health Today on Instagram at: https://www.instagram.com/behavioralhealthtoday/ Follow us on TikTok at: https://www.tiktok.com/@behavioralhealthtoday Follow us on Threads at: https://www.threads.net/@behavioralhealthtoday Or watch us live on YouTube at: https://www.youtube.com/channel/UCvOeCMGsF7B2gNBHuWxt-fQ

Your child's school library has a new genre: psychiatric propaganda for seven-year-olds. In his final solo episode, Dr. Roger McFillin goes full circle, back to the chemical imbalance lie he exposed in the very first episode five years ago. This time he follows it to where it lives now, in picture books written for second graders. He breaks down My Life with Anxiety, a children's book that teaches a little girl her butterflies are a lifelong condition, that avoiding sleepovers keeps her safe, and that relief comes from swallowing something. Then he turns to Psychiatry for Kids, co-written by a dermatologist, an ophthalmologist, and a pill-promoting social media psychiatrist. That book lists daydreaming, talking too much, and riding a skateboard as warning signs of mental illness, and it ends by telling your child exactly what they should become.This isn't education. It's recruitment into the psychiatry cult, delivered before a child is old enough to question it. Dr. McFillin explains how the propaganda works, why the people spreading it believe they're being kind, and what it means for a generation taught it's broken before it learns to read. He also answers the question every parent should be asking: why start with children?This is the last episode from the laptop where it all began. The new Radically Genuine launches Thursday, October 1st.

Originally released in 2024, this episode features the late Dr. Vladimir Maletic in conversation with Drs. Andy Cutler and Stephen Stahl about the clinical significance and neurobiology of anhedonia. They discuss its different dimensions, how it differs from emotional blunting, its relationship to functioning and treatment response, and practical approaches to assessment and treatment. The episode highlights why recovery from depression requires restoring interest, motivation, and pleasure—not simply reducing negative symptoms.  Vladimir Maletic, MD, MS, was a clinical professor of psychiatry and behavioral science at the University of South Carolina School of Medicine in Greenville and a consulting associate in the Division of Child and Adolescent Psychiatry at Duke University. Board certified in psychiatry and neurology, his areas of expertise included the neurobiology of mood disorders, schizophrenia, pain, and sleep–wake regulation.  Stephen M. Stahl, MD, PhD, DSc (Hon.), is a psychiatrist, psychopharmacologist, and internationally recognized educator in clinical neuroscience and psychopharmacology. He is the author of widely used educational resources, including Stahl's Essential Psychopharmacology and Stahl's Prescriber's Guide, and his work focuses on translating complex neurobiology and treatment mechanisms into practical clinical concepts for mental health clinicians.  Andrew J. Cutler, MD, is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and EMA Wellness. He is a Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.   Fall Congress  Get $100 off NEI Fall Congress registration with code POD26. Go to https://nei.global/fall to sign up today!  Membership  As a valued NEI Podcast listener, Dr. Cutler's offering you 20% off new NEI Membership with code CUTLER20. Go to https://nei.global/member and join now!  Never miss an episode!

How has our national discourse and our perception of national identity shifted in the 25 years after 9/11? And how can we heal from those traumatizing events? This hour, we talk about what we can learn from our response to 9/11 with a local psychiatrist who helped shape New York City's mental health response for its children. Plus, we look at how journalists coped with covering that day. GUESTS: John Woodall: Psychiatrist whose clinic is in Newtown. He is a former Harvard Medical School faculty, and founder of Healing the Heart of America. Sam Martin: Frank and Bethine Church Endowed Chair of Public Affairs at Boise State University. Dr. Anthony Feinstein: Professor of Psychiatry at University of Toronto and Sunnybrook Health Sciences Centre. He specializes in the psychological effects of covering war and violent conflict on journalists. Music featured (in order): Listen to the Heroes Cry – Christian McBride Loose Ends – Sergio Mendes, Justin Timberlake, Pharoahe Monch Don’t Let Me Be Misunderstood – Nina Simone We’re All Gonna Die – Joy Oladokun, Noah Kahan When Doves Cry – Prince Roll With the Punches – Randy Newman Support the show: http://www.wnpr.org/donateSee omnystudio.com/listener for privacy information.

EPISODE SUMMARY The qualities that help founders move fast, tolerate risk and pursue opportunities can also become liabilities under pressure. In this episode, psychiatrist, researcher and serial entrepreneur Michael A. Freeman joins Claudia to unpack the founder mental-health paradox: what the research really shows, when persistence becomes dangerous and how to catch warning signs before the founder—or the business—hits a wall.   WE TALKED ABOUT Why founder strengths can become hidden risks When persistence stops being productive How to spot and protect against mental-health warning signs   EPISODE NOTES Michael A. Freeman, M.D. is a psychiatrist, researcher and serial entrepreneur who studies mental health, wellbeing and performance among business builders. He and his colleagues at Econa developed the Founder Screen, a brief screening tool designed specifically for entrepreneurs. Michael has also served as a Clinical Professor of Psychiatry at U.C. San Francisco, founding Chief Medical Officer of United Behavioral Health, President of the Institute for Behavioral Healthcare and a mental-health team member of the White House Task Force on Health Care Reform. This conversation is educational and is not a substitute for individual medical or mental-health care. If emotional symptoms are affecting your wellbeing, performance or relationships, please seek appropriate professional support.   LINKS Econa: https://www.econa.net/ FounderScreen resources: https://founderscreen.org/resources Michael on LinkedIn: https://www.linkedin.com/in/michaelfreemanmd Click this link to listen on your favorite podcast player and, if you enjoy the show, please leave a rating and review: https://linktr.ee/wiredforsuccess   Music credit: Vittoro by Blue Dot Sessions (www.sessions.blue) Disclaimer: Podcast episodes might contain sponsored content.

Send us Fan MailAbout 20% of children experience bullying annually, although it's likely underreported. Now that children have been back to school for a few weeks, parents might want to check on their child for any problems at school. Our expert for this episode is James Barnett, Ph.D., clinical child and adolscent psycholigst at Texas Tech Physicians and assistant professor in the School of Medicine's Department of Psychiatry. Dr. Barnett defines what is considered bullying as defined by the state, warning signs to lok out for, how family members and caregivers should respond, including validating the child being bullied, how to report incidents and what long-term support is available. 

This was a highly informative, educational and eye-opening conversation with a brilliant woman who is a world leader in her field. Professor Jayashri Kulkarni AM is a psychiatrist, researcher and Professor of Psychiatry at Monash University, internationally recognised for her work in women’s mental health. A pioneer in psychoneuroendocrinology, her research explores how reproductive hormones influence the brain, mood and mental illness across menstruation, pregnancy, postpartum and menopause. With more than three decades in psychiatry, Jayashri has challenged traditional approaches to women’s mental health and helped reshape how biological, psychological and social factors are understood and treated.HER Centre AustraliaMultidisciplinary Alfred Psychiatry Research Centre (MAPrc)See omnystudio.com/listener for privacy information.

Ian Robertson, Emeritus Professor of Psychiatry, reflects on US President Donald Trump's comments about how Irish people are 'vicious' in business. See omnystudio.com/listener for privacy information.

ADHD, attachment, trauma, anxiety, and stress can look surprisingly similar. So how do you know what you're actually dealing with? Adam Lane Smith sits down with psychiatrist Dr. Steven Storage to unpack what ADHD really looks like, how it affects relationships, what a proper assessment involves, and where medication, sleep, nutrition, movement, and behavioral work fit in.

Andrew Scull is a historian of psychiatry. Thank you for listening ❤ Check out our sponsors: https://lexfridman.com/sponsors/ep502-sc See below for timestamps, transcript, and to give feedback, submit questions, contact Lex, etc. Transcript: https://lexfridman.com/andrew-scull-transcript CONTACT LEX: Feedback – give feedback to Lex: https://lexfridman.com/survey AMA – submit questions, videos or call-in: https://lexfridman.com/ama Hiring – join our team: https://lexfridman.com/hiring Other – other ways to get in touch: https://lexfridman.com/contact EPISODE LINKS: Andrew’s Website (UCSD faculty page): https://sociology.ucsd.edu/people/faculty/emeritus/andrew-scull.html Desperate Remedies (book): https://amzn.to/4vmBquI Madness in Civilization (book): https://amzn.to/3SZhd0I SPONSORS: To support this podcast, check out our sponsors & get discounts: Wispr Flow: AI-powered voice dictation app. Go to https://wisprflow.ai/lex Fin: AI agent for customer service. Go to https://fin.ai/lex LMNT: Zero-sugar electrolyte drink mix. Go to https://drinkLMNT.com/lex Shopify: Sell stuff online. Go to https://shopify.com/lex BetterHelp: Online therapy and counseling. Go to https://betterhelp.com/lex Perplexity: AI-powered answer engine. Go to https://perplexity.ai/ OUTLINE: (00:00) – Introduction (01:07) – Sponsors, Comments, and Reflections (08:10) – Crisis in Psychiatry (37:48) – Categories of Mental Illness (45:07) – Asylums, Eugenics, and the Nazis (57:13) – The Ice Pick Lobotomy (1:03:26) – Malaria “Cure” for Syphilis (1:21:42) – Insulin Coma Therapy (1:29:34) – Electroconvulsive Therapy (ECT) (1:49:03) – One Flew Over the Cuckoo’s Nest (2:06:35) – Freud and Psychoanalysis (2:36:30) – WWII and Cognitive behavioral therapy (CBT) (2:57:04) – Antipsychotics (3:20:24) – Antidepressants (3:33:18) – Future of Psychiatry PODCAST LINKS: – Podcast Website: https://lexfridman.com/podcast – Apple Podcasts: https://apple.co/2lwqZIr – Spotify: https://spoti.fi/2nEwCF8 – RSS: https://lexfridman.com/feed/podcast/ – Podcast Playlist: https://www.youtube.com/playlist?list=PLrAXtmErZgOdP_8GztsuKi9nrraNbKKp4 – Clips Channel: https://www.youtube.com/lexclips

Men die by suicide at dramatically higher rates than women, accounting for nearly 80% of suicide deaths. Yet many men who are struggling never seek mental health support — and the consequences can be deadly. On this episode, host Gabe Howard talks with psychiatrist Dr. Sanjay Mathew, board president of the Anxiety and Depression Association of America (ADAA), and Richard Reeves, president of the American Institute for Boys and Men and author of “Of Boys and Men: Why the Modern Male Is Struggling, Why It Matters, and What to Do About It.”The conversation explores why traditional mental health language and services may not resonate with some men, how anger and irritability can be overlooked warning signs, and why men may be reluctant to seek or continue treatment. They examine the importance of friendship, community, purpose, and feeling needed — and why men may sometimes hold themselves to such high standards that they count themselves out before they even begin.Listeners will learn: how adjusting the language around mental health may increase engagement among men why connection and belonging can be critical to men's well-being how friends and family can help prevent male suicide  why mental health treatment and therapy are a sign of strength, not weakness Most importantly, the episode challenges the idea that improving men's mental health means taking anything away from women. The goal, the guests argue, is not either/or — it's helping everyone thrive. Listen now to learn more. This episode has been sponsored by the Anxiety and Depression Association of America (ADAA).  “I think sending that message to men and perhaps especially to young men, ‘We need you,' is actually something that as a culture, we're not doing very well now.” ~Richard Reeves, author of “Of Boys and Men: Why the Modern Male Is Struggling, Why It Matters, and What to Do About It” Our guest, Richard V. Reeves, is the founder and president of the American Institute for Boys and Men (AIBM). Before founding AIBM in 2023, Reeves was a senior fellow at the Brookings Institution. While at Brookings, he focused on policies related to economic inequality, racial justice, social mobility, and boys and men. Reeves is the author of several books, including “Of Boys and Men: Why the Modern Male is Struggling, Why it Matters, and What to do About It” and “Dream Hoarders: How the American Upper Class Is Leaving Everyone Else in the Dust, Why That is a Problem, and What to do About It.” Inspired by his own experiences as a father and policy expert, Reeves founded AIBM to bring awareness to the challenges facing boys and men today and to develop evidence-based solutions. Our guest, Dr. Sanjay Mathew, is a professor and department head in the Department of Psychiatry & Behavioral Sciences at Texas A&M University's Naresh K. Vashisht College of Medicine. Our host, Gabe Howard, is an award-winning writer and speaker who lives with bipolar disorder. He is the author of the popular book, "Mental Illness is an Asshole and other Observations," available from Amazon; signed copies are also available directly from the author. Gabe is also the host of the "Inside Bipolar" podcast with Dr. Nicole Washington. Gabe makes his home in the suburbs of Columbus, Ohio. He lives with his supportive wife, Kendall, and a Miniature Schnauzer dog that he never wanted, but now can't imagine life without. To book Gabe for your next event or learn more about him, please visit gabehoward.com.

In this episode, Dr. Jeffrey Gladden and psychiatrist Dr. Matt Bernstein discuss the evolving landscape of mental health treatment. Bernstein shares his extensive experience in psychiatry, particularly with serious mental health conditions, and highlights the limitations of traditional medication approaches. He advocates for a more holistic view that considers metabolic health and mitochondrial function as critical components in understanding and treating mental health issues. The conversation also delves into the benefits of the ketogenic diet, cognitive flexibility, and the complexities of medication management in psychiatric care. In this conversation, Dr. Gladden and Matt Bernstein explore the intricate relationship between mental health, metabolism, exercise, and the role of psychedelics in therapy. They discuss the negative metabolic impacts of psychotropic medications, the significant benefits of exercise for mental health, and the importance of understanding individual genetics in managing depression. The conversation also delves into the role of lactate in brain health, mitochondrial function, and the potential of psychedelic therapies for personal transformation. Ultimately, they emphasize the need for a holistic approach to health that encompasses physical, mental, and spiritual well-being. For Audience Join the other 20,000+ high-performers getting weekly insights on biological reversal, exponential strategies, and Life Energy optimization→ https://start.gladdenlongevity.com/subscribe If you're ready to measure your 60+ biological ages and build a personalized reversal plan, apply for a discovery call here → https://start.gladdenlongevity.com/apply-now   Use code 'Podcast10' to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/!    Takeaways ·       Matt Bernstein has 26 years of experience in psychiatry. ·       He works with serious mental health conditions like bipolar disorder and schizophrenia. ·       Traditional psychiatric medications often lead to metabolic and neurological side effects. ·       Anhedonia is a significant issue in mental health, meaning a lack of pleasure. ·       There is a need for a fresh perspective on mental health rooted in metabolism. ·       Mitochondrial dysfunction is linked to serious mental illnesses. ·       The ketogenic diet can be an effective intervention for mental health. ·       Cognitive flexibility is crucial for managing mental health conditions. ·       Medication management is complex and requires careful consideration. ·       Not all patients can or should stop their medications completely. Psychotropic medications can negatively impact metabolic health. ·       Exercise has a greater effect on depression than antidepressants. ·       Intense exercise is crucial for mental health benefits. ·       Genetics play a significant role in individual responses to depression. ·       Lactate production during exercise is beneficial for brain health. ·       Mitochondrial health is essential for longevity and mental well-being. ·       Stress affects both neurological and hormonal health. ·       Psychedelic therapies can provide transformative experiences for some individuals. ·       Social connectedness and purpose are vital for longevity. ·       Holistic approaches to health should integrate physical, mental, and spiritual aspects.   Chapters 00:00 Introduction to Mental Health Perspectives 02:58 The Limitations of Traditional Psychiatry 05:54 Exploring Root Causes in Mental Health 09:05 The Role of Metabolism and Mitochondrial Function 11:54 The Ketogenic Diet as a Therapeutic Approach 14:59 Cognitive Flexibility and Mental Health 17:56 Medication Management in Psychiatric Care 23:24 Impact of Psychotropics on Metabolism 24:49 The Role of Exercise in Mental Health 27:53 Genetics and Personal Insights on Depression 29:32 Lactate Production and Brain Health 32:46 Mitochondrial Health and Longevity 36:30 Mind-Body Connection and Stress Management 39:08 Psychedelic-Assisted Therapies 45:07 Optimizing Longevity and Health Span To learn more about Dr. Matt Bernstein:Website: www.accordmh.com LinkedIn: www.linkedin.com/in/mattbernsteinmd   Reach out to us at:    Website: https://gladdenlongevity.com/     Facebook: https://www.facebook.com/Gladdenlongevity/    Instagram: https://www.instagram.com/gladdenlongevity/?hl=en     LinkedIn: https://www.linkedin.com/company/gladdenlongevity    YouTube: https://www.youtube.com/channel/UC5_q8nexY4K5ilgFnKm7naw    

When reporters cover mass shootings news outlets often struggle to find ways to cover the event that won't inspire others to do the same thing. Something similar follows in the wake of a suicide. Journalists don't always cover suicides in their communities but when they do one of the concerns is whether that coverage might lead to a spike in suicides after the story is out. The media's influence on the actions of individuals is a chronic concern for researchers in a number of fields and is a focus of this episode of Stats and Stories with guest Joel Greenhouse Joel B. Greenhouse, Ph.D., is Professor of Statistics at Carnegie Mellon University, and Adjunct Professor of Psychiatry and Epidemiology at the University of Pittsburgh. He is an elected Fellow of the American Statistical Association, the American Association for the Advancement of Science, and an elected Member of the International Statistical Institute. Why did you study 13 Reasons Why? (1:23) What data did you use in this? (2:20) How did you choose the age ranges? (7:40) Editing the episode (9:45) What're the limitations of this research (10:56) Correlation/causation issues? (13:21) Any outrageous stories about your work? (15:02) Most surprising result of your work? (16:15) Contagion with suicide (18:24) How would you follow this study up? (20:23)

Schizophrenia has long been intertwined with the anti-psychiatry movement. The anti-psychiatry movement is based on the belief that psychiatric treatments often cause more harm than good. It challenges the legitimacy of mental illness diagnoses, medical interventions, and institutional authority. But the anti-psychiatry movement has also helped to significantly transform modern mental health care, patient rights, and legal, ethical, and clinical reforms. Host Rachel Star Withers, a diagnosed schizophrenic, and co-host Gabe Howard  break down the core parts of the ever evolving anti-psychiatry movement and how to navigate it as someone with schizophrenia and their loved ones. Guest Psychiatrist Dr. Daniel Morehead joins. He is an advocate for mental health and the author of Science Over Stigma: Education and Advocacy for Mental Health, published by the American Psychiatric Association. Our guest, Dr. Daniel Morehead, is a psychiatrist and director of training for the general psychiatry residency at Tufts Medical Center in Boston. He frequently speaks as an advocate for mental health and is author of Science Over Stigma: Education and Advocacy for Mental Health, published by the American Psychiatric Association. Our host, Rachel Star Withers, (Link: www.rachelstarlive.com) is an entertainer, international speaker, video producer, and schizophrenic. She has appeared on MTV's Ridiculousness, TruTV, NBC's America's Got Talent, Marvel's Black Panther, TUBI's #shockfight, Goliath: Playing with Reality, and is the host of the HealthLine podcast “Inside Schizophrenia”. She grew up seeing monsters, hearing people in the walls, and having intense urges to hurt herself. Rachel creates videos documenting her schizophrenia, ways to manage, and letting others like her know they are not alone and can still live an amazing life. She has created a kid's mental health comic line, The Adventures of ____. (Learn more at this link: https://www.amazon.com/Adventures-Fearless-Unstoppable-Light-Ambitious/dp/B0FHWK4ZHS ) Fun Fact: She has wrestled alligators. Our cohost, Gabe Howard, is an award-winning writer and speaker who lives with bipolar disorder. He is the author of the popular book, "Mental Illness is an Asshole and other Observations," available from Amazon; signed copies are also available directly from the author. He also hosts the twice Webby honored podcast, Inside Bipolar, with Dr. Nicole Washington. To learn more about Gabe, please visit his website, gabehoward.com. Please share the show with everyone you know so we can grow! Thank you. Learn more about your ad choices. Visit megaphone.fm/adchoices

Jaimi and Jess digest the news that The Royal College for Psychiatry have released an official apology statement to all victims of CSA - for pathologising them, gaslighting them and even diagnosing them… but what happens next?

Today, we will discuss GLP-1's and the emerging use of this class of medications in psychiatry.Sources:https://pubmed.ncbi.nlm.nih.gov/42247271/https://pmc.ncbi.nlm.nih.gov/articles/PMC11441540/https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2838205https://pubmed.ncbi.nlm.nih.gov/42070571https://pubmed.ncbi.nlm.nih.gov/41806782/

Dr. Joyce Maguire Pavao, Ed.D., LCSW, LMFT is a returning guest.She was the Founder and CEO of Center for Family Connections, Inc. in Cambridge and New York, Founder and Director of Riverside After Adoption Consulting and Training, PACT (Pre/Post Adoption Consulting and Training, and Pavao Consulting and Coaching. Dr. Pavao has done extensive training, both nationally and internationally. She is a lecturer in Psychiatry at Harvard Medical School, and she has consulted to various public and private child welfare agencies, adoption agencies, schools, and community groups, as well as probate and family court judges, lawyers, and clergy. Additionally, she has worked closely with individuals and families touched by adoption, foster care, and other complex blended family constructions. She has developed models for treatment, and models for training, using her systemic, intergenerational, and developmental framework, The Normative Crises in the Development of the Adoptive Family. Her book, The Family of Adoption, has received high acclaim. Dr. Pavao has received many awards and honors, including the Children's Bureau/U.S. Department of Health and Human Services Adoption Excellence Award for Family Contribution (2003) and the Congressional Coalition on Adoption award for Angels in Adoption (2000).Music by Corey Quinn

You've heard of an OB-GYN. You've probably heard of a psychiatrist. But have you ever heard of a reproductive psychiatrist?If the answer is no, you're not alone.In this episode, Sarah sits down with reproductive psychiatrist Dr. Claire Smith to explain why one of the most important specialties in maternal mental health remains one of the least known. Together, they discuss what reproductive psychiatry is, why so few specialists exist, how this training differs from general psychiatry, and why so many women never learn this specialty is available until they're already struggling.Follow Previa Alliance!Previa Alliance (@previa.alliance) • Instagram photos and videosPrevia Alliance Podcast (@previapodcast) • Instagram photos and videosKeep the questions coming by sending them to info@previaalliance.com or DM us on Instagram!

Trust is not all or nothing.

Your primary care provider is doing their best. But there's something they may not be telling you — not because they're hiding it, but because they simply can't know everything.In this episode of Your Health University, Jamie Preston sits down with Scott Middleton — Founder and Chief Disruption Officer of Your Health — to talk about one of the most underutilized parts of the American healthcare system: specialty care. Scott shares real stories from the field that will make you rethink what you expect from your next appointment, including a patient who had been living in a nursing home for years without ever being offered a weight-loss medication that was available to her, and a lawsuit that turned on a single chest x-ray that no one thought to order.What you'll learn in this episode:Why your primary care provider legally cannot keep up with every new medication, treatment, and specialist recommendation — and what to do about itWhat GLP-1 medications are, who qualifies, and why so many eligible patients are never told they existThe standard of care around lung cancer screening for smokers — and why not knowing this can have life-altering consequencesHow to ask for a specialist referral (and what happens if your provider pushes back)Why behavioral health is one of the most under-accessed specialties in America — and how to change that for yourselfWhat "integrated care" actually looks like when it works — and what you deserve to expect from your healthcare teamYou are the CEO of your own health. This episode gives you tools to act like it. www.YourHealth.Org

Get the 200+ Page Optimal Living Daily Workbook (PDF) - Free. Want to turn today's episode into an actionable plan? Join the Optimal Living Weekly newsletter and I'll send you our 200-page digital workbook immediately. It's packed with the best takeaways from the show, formatted for easy reading and implementation at home. Get your free PDF workbook here: https://oldpodcast.eo.page/join Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com Episode 3534: Elana Miller shares what she learned while waiting to find out whether treatment for a cancer relapse had worked, and why she came to see fear as harder to live with than death itself. She describes passing the 100-day mark after her stem cell transplant and the ordinary pleasures that followed it. Her reflection is on resilience, and on the quiet value of days that turn out to be unremarkable. Read along with the original article(s) here: https://zenpsychiatry.com/living-to-100-days/ Quotes to ponder: "The reason I wanted to die quickly is that I've learned there is something worse than death, and it is fear." "I live each day as if I have all the time in the world, and that makes me happy." "There is a joy in being ordinary, in having the same petty worries and pleasures of a regular person who hasn't repeatedly had to contemplate their own death." Optimal Health Daily is a daily health and wellness podcast where we narrate the best articles on nutrition, fitness, weight loss, and healthy habits, read to you by a professional narrator so you can improve your health a little more every day. Learn more about your ad choices. Visit megaphone.fm/adchoices

When states began legalizing recreational cannabis a couple decades ago, 25 million Americans said they used the drug. That number nearly tripled to 70 million by 2023.There are a lot of open questions about how it affects us. Why do some people find more pain relief from THC than traditional painkillers? Is it really better for sleep? What are the effects of long-term use?Host Flora Lichtman is joined by two scientists taking on these kinds of questions: Experimental psychologist Ryan Vandrey, who's studied the health effects of cannabis for 26 years, and neuropsychologist Natasha Wade, who studies the effects of substance abuse on adolescent brains. She recently analyzed data from 11,000 teens to understand how cannabis affects development.Guests:Dr. Ryan Vandrey is an experimental psychologist and professor at the Johns Hopkins University Behavioral Pharmacology Research Unit and helps lead the Johns Hopkins Cannabis Science Lab.Dr. Natasha Wade is an associate professor in the Department of Psychiatry at UC San Diego and licensed clinical neuropsychologist.Transcript will be available after the show airs on sciencefriday.com. Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that's keeping you up at night? Call us: 877-472-4374 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this season 8 opener Rosy shares both her experience recovering from bipolar disorder and the heartbreak of watching her beloved son begin to show signs of an even more extreme form of bipolar disorder called schizoaffective disorder. This is a story in parallel, two lives deeply intertwined, yet also slowly tearing apart as her son's illness became increasingly severe.Support the showElemental Psychedelicshttps://www.elementalpsychedelics.com/Explore every episode through themes, domains, formats, and speakers. The BFTA CODEX is a listener-built and curated field guide to the podcast. https://bfta-codex.orgBFTA episode recommendations/Podcast pagehttps://www.craigheacockmd.com/podcast-page/BFTA on IG @backfromtheabysspodcasthttps://www.instagram.com/backfromtheabysspodcast/Support the show

Dr. Mel Houser, MD, physician and founder of the All Brains Belong health care community, explains how current healthcare systems fail neurodivergent people. Dr. Mel explains how traditional healthcare settings create barriers that don't accommodate neurodivergent needs, and how practices in All Brains Belong, guided by universal design principles, emphasize the importance of elevating lived expertise by telling patients “you are the expert in your body.” The discussion also covered how neurodivergent people often present with intertwined neuroimmune conditions that traditional 10-15 minute medical visits cannot properly address. Dr. Mel concluded by outlining three concrete changes needed in American healthcare systems.Find out more on our websiteSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Have you ever been completely stuck trying to solve a problem or come up with a new idea? There is a remarkably simple thing you can do that research shows can get your creative juices flowing. And it works surprisingly well. https://news.stanford.edu/stories/2014/04/walking-vs-sitting-042414 Can you actually think yourself sick? Absolutely. It's called the nocebo effect — essentially the evil twin of the placebo effect. If a doctor warns you that a medication might cause certain side effects, simply hearing that can make those symptoms more likely to occur. The same thing can happen when you read about an illness or medication online. Your expectations can trigger very real physical symptoms. So how does that happen — and how do you protect yourself from it? Helen Pilcher is a science writer with a PhD in neuroscience from London's Institute of Psychiatry, and she has some remarkable examples of the nocebo effect in action. She is author of This Book May Cause Side Effects: The Curious and Dangerous Power of the Nocebo Effect, Placebo's Evil Twin (https://amzn.to/4qvrdLU). Why are sideburns called sideburns? How could the first automatic door possibly have been invented before the birth of Christ? And where in the world did the word dude come from? Those are just a few of the strange facts and curious word origins explored by Jess Zafarris. She joins me to reveal some fascinating bits of history and language that will leave you with plenty of things you never knew you wanted to know. Jess is co-author of A Miscellany of Weird and Wonderful Facts for Curious Humans Who Have Nothing Better to Do Than Read (https://amzn.to/4wFtLZq). When you say something embarrassing, have a bad hair day or just feel awkward in a group, it can seem as if everyone notices. But how closely are other people really paying attention to you? Psychologists have studied this, and what they discovered should make your next embarrassing moment a little easier to handle. https://www.psychologytoday.com/us/articles/199612/why-bad-hair-days-may-not-matter PLEASE SUPPORT OUR SPONSORS MONARCH: Write your own money story with Monarch! Use promo code SYSK at ⁠https://Monarch.com⁠ to get your 1st year of Monarch Core half off at just $50 AQUATRU: Head to ⁠https://AquaTru.com⁠ now and get 20% off your purifier using promo code SYSK AquaTru even comes with a 30-day best-tasting water guarantee or your money back! WAYFAIR: Ready to upgrade your home for way less? Head to ⁠⁠⁠⁠⁠⁠⁠⁠⁠https://Wayfair.com⁠⁠⁠⁠⁠⁠⁠⁠⁠ right now to shop all things home and get your space ready for less.  QUINCE: Find your next Fall favorites at Quince! Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://Quince.com/sysk⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for free shipping on your order and 365-day returns. Now available in Canada, too! DELL: Built for those who want better. The Dell XPS, built for you! INDEED: Get a $75 Sponsored Job credit to help get your job the premium status it deserves at ⁠⁠⁠⁠⁠⁠⁠⁠https://Indeed.com/PODCAST⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Philosopher Stefan Molyneux talks about the Lindsay Clancy mistrial after the jury could not agree. He looks at why the insanity defense is so hard to prove years later, the evidence on her medications and state of mind, and why we should not build a life with someone who rejects facts for feelings.JOIN ME IN NASHVILLE SEPTEMBER 12! https://wordwardebate.com/Use code STEFAN for 10% off!GET FREEDOMAIN MERCH! https://shop.freedomain.com/SUBSCRIBE TO ME ON X! https://x.com/StefanMolyneuxFollow me on Youtube! https://www.youtube.com/@freedomain1GET MY NEW BOOK 'PEACEFUL PARENTING', THE INTERACTIVE PEACEFUL PARENTING AI, AND THE FULL AUDIOBOOK!https://peacefulparenting.com/Join the PREMIUM philosophy community on the web for free!Subscribers get 12 HOURS on the "Truth About the French Revolution," multiple interactive multi-lingual philosophy AIs trained on thousands of hours of my material - as well as AIs for Real-Time Relationships, Bitcoin, Peaceful Parenting, and Call-In Shows!You also receive private livestreams, HUNDREDS of exclusive premium shows, early release podcasts, the 22 Part History of Philosophers series and much more!See you soon!https://freedomain.locals.com/support/promo/FREEDOMAIN2026